Risk Factors for Implantable Defibrillator Lead Fracture in a Recalled and a Nonrecalled Lead
Authors:
- David O. HodgeDHDavid O. Hodge
- Daniel CrusanDCDaniel Crusan
- David BradleyDBDavid Bradley
- Paul A. FriedmanPFPaul A. Friedman
- 17 May 2010
- journal article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 21 (6) , 671-677
Abstract
Risk Factors for ICD Lead Fracture. Introduction: The Medtronic Sprint Fidelis® implantable cardioverter defibrillator (ICD) lead was “recalled” in October 2007 after 268,000 implants worldwide due to increased failure risk. Manufacturer suggested monitoring has not been shown effective at preventing adverse events. Only limited data exist regarding clinical predictors of Fidelis® lead fracture. We sought to identify risk factors for Fidelis® fracture to guide clinical monitoring and compare its performance with a control lead. Methods: Fractured lead cases were retrospectively reviewed for demographic data, implant technique, radiographic appearance and clinical presentation was analyzed. Lead survival was compared using Kaplan‐Meir curves. Results: Study patients (n = 1314) experienced 18 Fidelis® and 6 Quattro™ lead fractures. Patients with failed Fidelis® leads were younger than those with surviving leads (49.5 vs 64.6 years, P = 0.0066). Fidelis® lead fractures often occurred around the time of physical activity. No other measured demographic or technique related factors were associated with lead fracture. Fidelis® leads had significantly decreased survival compared with Quattro™ leads (89.3 vs 98.9% at 30 months). Patients less than 50 years old had significantly decreased lead survival compared with those older than 50 in both Fidelis® (79.6% vs 96.5% at 24 months) and Quattro™ (93.4 vs 99.8%, P < 0.001 at 24 months) leads. Conclusions: Patients under age 50, with either Fidelis® or Quattro™ ICD leads, are at increased risk of lead fracture compared with patients over 50, particularly around the time of intense physical activity. Aggressive monitoring and advisory programming appears warranted in patients with Fidelis® leads as well as especially in younger patients. (J Cardiovasc Electrophysiol, Vol. 21, pp. 671‐677, June 2010)Keywords
This publication has 30 references indexed in Scilit:
- Proceedings of the ICD Lead Performance ConferenceHeart Rhythm, 2008
- Implantable Cardioverter-Defibrillator Lead PerformanceCirculation, 2008
- Sensing Failure Associated with the Medtronic Sprint Fidelis Defibrillator LeadJournal of Cardiovascular Electrophysiology, 2007
- Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and GuidelinesHeart Rhythm, 2006
- Biventricular implantable cardioverter-defibrillator in the elderlyHeart Rhythm, 2005
- Automatic Identification of Clinical Lead DysfunctionsPacing and Clinical Electrophysiology, 2005
- High Incidence of Appropriate and Inappropriate ICD Therapies in Children and Adolescents with Implantable Cardioverter DefibrillatorPacing and Clinical Electrophysiology, 2004
- Detection and management of animplantable cardioverter defibrillator lead failureJACC, 2003
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- Report of the Policy Conference of NASPE on Device/Lead Performance and the Development of a Postmarket Surveillance DatabasePacing and Clinical Electrophysiology, 1993